News

Here you’ll find the latest press releases issued by Centenara Labs and its portfolio companies. Scroll down to discover more stories about our science, our business and our people.

Press releases

Filter

Press releases

Rejuveron Life Sciences AG Rebrands as Centenara Labs AG and Provides Latest Clinical Updates

September 19, 2024

Press releases

Rejuveron raises $75 million in dual tranche Series B and convertible loan financing to support healthy aging and accelerate presence in the Middle East

September 10, 2023

Press releases

Second Rejuveron company transitions into clinical stage as first patient is dosed in trial of Endogena Therapeutics’ novel regenerative treatment for blindness caused by retinitis pigmentosa

July 11, 2022

Press releases

Rejuveron CEO and Co-Founder Matthias Steger named as a 2022 In Vivo Rising Leader

April 18, 2022

Press releases

Rejuveron Transitions to Become a Clinical Stage Company as Rejuvenate Biomed Starts Ground-breaking Clinical Trial in Age-Related Muscle Wasting Disease, Sarcopenia

March 28, 2022

Press releases

Rejuveron Increases to Near-majority Stake in Endogena Through Funding $20m to Progress Treatments for Degenerative Diseases of the Eye

December 12, 2021

Press releases

Rejuveron Appoints Roche Veteran Bob Silverman as Chief Business Officer and Opens US Operations in New York

November 18, 2021

Press releases

Rejuveron leads EUR 15.7 million Series B investment in Rejuvenate Biomed to accelerate clinical development of its sarcopenia treatment for healthy aging

October 11, 2021

16.06.2022

Global Meetup in Zürich

04.05.2022

“Aging intersects with absolutely every other aspect of human experience”

03.05.2022

“My survival instinct sparked me to get into aging research”

13.04.2022

Rejuveron Age Better Live Longer Symposium

09.03.2022

Researchers at Rejuveron deploy knowledge gained in Nobel prize-winning techniques to crack catalysis conundrums

08.12.2021

Our sponsored feature in nature describes our vision to make therapies happen

03.11.2021

Women in Biotech – What does it take to increase gender equality in biotech?

30.09.2021

Forget Generations XYZ, welcome to Generation Health

30.09.2021

Join the Rejuveron Age Better, Live Longer Symposium

20.07.2021

Make your research work: scientific freedom with sustainable support

19.07.2021

Make your future at Rejuveron: from valves and pipes to leading longevity discovery

14.12.2020

News

Here you’ll find the latest press releases issued by Centenara Labs and its portfolio companies. Scroll down to discover more stories about our science, our business and our people.

Press releases

Filter

Rejuveron Life Sciences AG Rebrands as Centenara Labs AG and Provides Latest Clinical Updates

Rejuveron raises $75 million in dual tranche Series B and convertible loan financing to support healthy aging and accelerate presence in the Middle East

Second Rejuveron company transitions into clinical stage as first patient is dosed in trial of Endogena Therapeutics’ novel regenerative treatment for blindness caused by retinitis pigmentosa

Rejuveron CEO and Co-Founder Matthias Steger named as a 2022 In Vivo Rising Leader

Rejuveron Transitions to Become a Clinical Stage Company as Rejuvenate Biomed Starts Ground-breaking Clinical Trial in Age-Related Muscle Wasting Disease, Sarcopenia

Rejuveron Increases to Near-majority Stake in Endogena Through Funding $20m to Progress Treatments for Degenerative Diseases of the Eye

Rejuveron Appoints Roche Veteran Bob Silverman as Chief Business Officer and Opens US Operations in New York

Rejuveron leads EUR 15.7 million Series B investment in Rejuvenate Biomed to accelerate clinical development of its sarcopenia treatment for healthy aging

Global Meetup in Zürich

MORE

“Aging intersects with absolutely every other aspect of human experience”

MORE

“My survival instinct sparked me to get into aging research”

MORE

Rejuveron Age Better Live Longer Symposium

MORE

Researchers at Rejuveron deploy knowledge gained in Nobel prize-winning techniques to crack catalysis conundrums

MORE

Our sponsored feature in nature describes our vision to make therapies happen

MORE

Women in Biotech – What does it take to increase gender equality in biotech?

MORE

Forget Generations XYZ, welcome to Generation Health

MORE

Join the Rejuveron Age Better, Live Longer Symposium

MORE

Make your research work: scientific freedom with sustainable support

MORE

Make your future at Rejuveron: from valves and pipes to leading longevity discovery

MORE

Rejuveron Senescence Therapeutics: Bringing senescent cells out of hiding

MORE